Catalpol inhibits LPS plus IFN-γ-induced inflammatory response in astrocytes primary cultures

Toxicology in Vitro

Volumn 27, Issue 2, 2013, Pages 543-550

  Bi, Jing ^a,b   Jiang, Bo ^a   Zorn, Andrew ^c   Zhao, Rong Guo ^d   Liu, Peng ^b   An, Li Jia ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MISSOURI   (United States)

^d Guoren Biological Technology Co Ltd   (China)

Author keywords

Astrocyte; Catalpol; LPS; Neuroinflammation; NF B

Indexed keywords

CATALPOL; CYCLOOXYGENASE 2; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MOUSE; NERVE CELL STIMULATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; CELLS, CULTURED; CYCLOOXYGENASE 2; DRUGS, CHINESE HERBAL; GENE EXPRESSION; INFLAMMATION; INTERFERON-GAMMA; IRIDOID GLUCOSIDES; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

EID: 84875244378     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.09.023     Document Type: Article

References (51)

1. Akira S. Toll-like receptor signaling. J. Biol. Chem. 2003, 278(40):38105-38108.
2. Akira S., Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 4:499-511.
3. Arroyo D.S., Soria J.A., Gaviglio E.A., Rodriguez G.M.C., Iribarren P. Toll-like receptors are key players in neurodegeneration. Int. Immunopharmacol. 2011, 11(10):1415-1421.
4. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 2001, 107:241-246.
5. Balistreri C.R., Grimaldi M.P., Chiappelli M., Licastro F., Castiglia L., Listì F., Vasto S., Lio D., Caruso C., Candore G. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer'sdisease. Curr. Pharm. Des. 2008, 14(26):2672-2677.
6. 2-induced oxidative stress in astrocytes primary cultures. Neurosci. Lett. 2008, 442:224-227.
7. Bi J., Wang X.B., Chen L., Hao S., An J.A., Bo Jiang, Guo L. Catalpol protects mesencephalic neurons against MPTP induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity. Toxicol. In Vitro 2008, 22:1883-1889.
8. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Castro-Alcaraz S., Miskolci V., Kalasapudi B., Davidson D., Vancurova I. NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis. J. Immunol. 2002, 169:3947-3953.
10. Chen C., Magee J.C., Bazan N.G. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 2002, 87:2851-2857.
11. Cheong M.H., Lee S.R., Yoo H.S., Jeong J.W., Kim G.Y., Kim W.J., Jung I.C., Choi Y.H. Anti-inflammatory effects of Polygala tenuifolia root through inhibition of NF-κB activation in lipopolysaccharide-induced BV2 microglial cells. J. Ethnopharmacol. 2011, 137(3):1402-1408.
12. Davis R.L., Sanchez A.C., Lindley D.J., Williams S.C., Syapin P.J. Effects of mechanistically distinct NF-kappaB inhibitors on glia inducible nitric-oxide synthase expression. Nitric Oxide 2005, 12:200-209.
13. Delhase M., Li N., Karin M. Kinase regulation in inflammatory response. Nature 2000, 406:367-368.
14. Esposito E., Di Matteo V., Benigno A., Pierucci M., Crescimanno G., Di Giovanni G. Non-steroidal anti-inflammatory drugs in Parkinson's disease. Exp. Neurol. 2007, 205:295-312.
15. Font-Nieves M., Sans-Fons M.G., Gorina R., Bonfill-Teixidor E., Salas-Pérdomo A., Márquez-Kisinousky L., Santalucia T., Planas A.M. Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes. J. Biol. Chem. 2012, 287(9):6454-6468.
16. Gandhi S., Abramov A.Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell. Longev. 2012, Published online. 10.1155/2012/428010.
17. 15N] nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
18. Haddad J.J. Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem. Biophys. Res. Commun. 2002, 296:847-856.
19. Heales S.J., Bolanos J.P. Impairment of brain mitochondrial function by reactive nitrogen species: the role of glutathione in dictating susceptibility. Neurochem. Int. 2002, 40:469-474.
20. Heales S.J., Lam A.A., Duncan A.J., Land J.M. Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem. Res. 2004, 29:513-519.
21. Jeohn G.H., Kim W.G., Hong J.S. Time dependency of the action of nitric oxide in lipopolysaccharide-interferon-c-induced neuronal cell death in murine primary neuron-glia co-cultures. Brain Res. 2000, 880:173-177.
22. Jiang B., Du J., Liu J.H., Bao Y.M., An L.J. Catalpol attenuates the neurotoxicity induced by b-amyloid1-42 in cortical neuron-glia cultures. Brain Res. 2008, 1188:139-147.
23. Jin D.-Q., Lim C.S., Hwang J.K., Ha I., Han J.-S. Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochem. Biophys. Res. Commun. 2005, 331:1264-1269.
24. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621-663.
25. Kiyoshi T., Shizuo A. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17(1):1-14.
26. Klegeris A., McGeer E.G., McGeer P.L. Therapeutic approaches to inflammation in neurodegenerative disease. Curr. Opin. Neurol. 2007, 20:351-357.
27. Klein J.A., Ackerman S.L. Oxidative stress, cell cycle, and neurodegeneration. J. Clin. Invest. 2003, 111:785-793.
28. Knott A.B., Bossy-Wetzel E. Impact of nitric oxide on metabolism in health and age-related disease. Diabetes Obes. Metab. 2010, 12(Suppl 2):126-133.
29. Kong Y., Le Y. Toll-like receptors in inflammation of the central nervous system. Int. Immunopharmacol. 2011, 11(10):1407-1414.
30. Koppula S., Kumar H., Kim I.S., Choi D.K. Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease. Mediators Inflamm 2012, Published online 2012, April 22. 10.1155/2012/823902.
31. Lee H., Kim Y.O., Kim H., Kim S.Y., Noh H.S., Kang S.S., Cho G.J., Choi W.S., Suk K. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 2003, 17:1943-1944.
32. Lee J., Ryu H., Ferrante R.J., Morris S.M.J., Ratan R.R. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. U S A 2003, 100:4843-4848.
33. Lee J.W., Lee M.S., Kim T.H., Lee H.J., Hong S.S., Noh Y.H., Hwang B.Y., Ro J.S., Hong J.T. Inhibitory effect of inflexinol on nitric oxide generation and iNOS expression via inhibition of NF-κB activation. Mediators of inflammation 2007, 2007:1-9.
34. Li Y.C., Bao Y.M., Jiang B., Wang Z., Liu Y.X., Zhang C., An L.J. Catalpol protects primary cultured astrocytes from in vitro ischemia-induced damage. Int. J. Dev. Neurosci. 2008, 26:309-317.
35. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005, 5:446-458.
36. Magnani M., Crinelli R., Bianchi M., Antonelli A. The ubiquitin dependent proteolytic system and other potential targets for the modulation of nuclear factor-κB (NF-κB). Curr. Drug Targets 2000, 1:187-399.
37. Nagayama M., Niwa K., Nagayama T., Ross M.E., Iadecola C. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J. Cereb. Blood Flow Metab. 1999, 19:1213-1219.
38. Palomba L., Amadori A., Cantoni O. Early release of arachidonic acid prevents an otherwise immediate formation of toxic levels of peroxynitrite in astrocytes stimulated with lipopolysaccharide/interferon-γ. J. Neurochem. 2007, 103:904-913.
39. Panaro M.A., Lofrumento D.D., Saponaro C., De Nuccio F., Cianciulli A., Mitolo V., Nicolardi G. Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson'-like disease. Immunopharmacol. Immunotoxicol. 2008, 30(4):729-740.
40. Rockwell P., Yuan H., Magnusson R., Figueiredo-Pereira M.E. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch. Biochem. Biophys. 2000, 374:325-333.
41. Saha R.N., Pahan K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem. Int. 2006, 49:154-163.
42. Sawa T., Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 2006, 14:91-100.
43. Singh S., Swarnkar S., Goswami P., Nath C. Astrocytes and microglia: responses to neuropathological conditions. Int. J. Neurosci. 2011, 121(11):589-597.
44. Spilsbury A., Vauzour D., Spencer J.P., Rattray M. Regulation of NF-κB activity in astrocytes: effects of flavonoids at dietary-relevant concentrations. Biochem. Biophys. Res. Commun. 2012, 418(3):578-583.
45. Surendran S., Rajasankar S. Parkinson's disease: oxidative stress and therapeutic approaches. Neurol. Sci. 2010, 31(5):531-540.
46. Tian Y.Y., An L.J., Jiang L., Duan Y.L., Chen J., Jiang B. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures. Life Sci. 2006, 80(3):193-199.
47. Tuppo E.E., Arias H.R. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 2005, 37:289-305.
48. Wang H., Joseph J. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.
49. Zhang X.L., Jiang B., Li Z.B., Hao S., An L.J. Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose. Pharmacol. Biochem. Behav. 2007, 88:64-72.
50. Zhang A.H., Hao S., Bi J., Bao Y.M., Zhang X.L., An L.J., Bo J. Effects of catalpol on mitochondrial function and working memory in mice after lipopolysaccharide-induced acute systemic inflammation. Exp. Toxicol. Pathol. 2009, 61:461-469.
51. Zhang S., Chen X., Yang Y., Zhou X., Liu J., Ding F. Neuroprotection against cobalt chloride-induced cell apoptosis of primary cultured cortical neurons by salidroside. Mol. Cell. Biochem. 2011, 354(1-2):161-170.